Both galectin-3 (r=0.306, p=0.010) and FGF-23 (r=0.332, p=0.005) correlated with ASCVD risk score in bivariate Spearman's correlation analysis, but these correlations were not retained in binary logistic regression analysis.<h4>Conclusions</h4>Serum galectin-3 levels but not FGF-23 are higher in T2D patients. This evidence concerns the gene FGF23 and type 2 diabetes mellitus.